Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
27.11 USD +5.12% Intraday chart for Protagonist Therapeutics, Inc. +6.06% +18.23%
May. 07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT
2d2b3983f6ff2517ee43837ee1d2b3.HUsnURHIpwvCE1lj5O0m4m8ChlbWnhlItRES5ALnQes.RxRkGVe_02-Ka2paoK5jqTlr9mKZ3WA99lBl10jQFNNvfUUmZob0QIRJLg~0a0d2a099f4f66833f213d8189a25479
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Charts Protagonist Therapeutics, Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW